In pursuit of new developments for gene therapy of human diseases

This publication has 54 references indexed in Scilit:

• Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector
  Nature Biotechnology, 1997
• Persistence in muscle of an adenoviral vector that lacks all viral genes
  Proceedings of the National Academy of Sciences, 1997
• Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
  Proceedings of the National Academy of Sciences, 1996
• In VitroandIn VivoHepatoma Cell-Specific Expression of a Gene Transferred with an Adenoviral Vector
  Human Gene Therapy, 1996
• Intrathecal delivery of CNTF using encapsulated genetically modifiedxenogeneic cells in amyotrophic lateral sclerosis patients
  Nature Medicine, 1996
• T Lymphocyte-Directed Gene Therapy for ADA ⁻ SCID: Initial Trial Results After 4 Years
  Science, 1995
• A Retroviral Vector Containing a Muscle-Specific Enhancer Drives Gene Expression Only in Differentiated Muscle Fibers
  Human Gene Therapy, 1995
• Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.
  Proceedings of the National Academy of Sciences, 1995
• Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver.
  Proceedings of the National Academy of Sciences, 1994
• Novel proteins associated with MHC class I antigens in cells expressing the adenovirus protein E3/19K.
  The EMBO Journal, 1993